亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

胞苷-5'-二磷酸膽堿CAS號: 987-78-0

 
 
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 987-78-0
過期 長期有效
更新 2020-06-18 10:08
 

隨州市紅旗化工有限公司

企業會員第15年
資料未認證
保證金未繳納
詳細說明

胞苷-5'-二磷酸膽堿
CAS號: 987-78-0
中文同義詞: 胞苷二磷酸膽堿酯;膽磷膽堿;腦二磷膽堿;胞苷-5'-二磷酸膽堿;胞二磷膽堿 CDP);胞嘧啶核苷二磷酸膽堿;二磷酸胞嘧啶膽堿;尼古林
英文名稱: CYTIDINE 5'-DIPHOSPHOCHOLINE
英文同義詞: CITICOLINE;CYTIDINE 5'-DIPHOSPHOCHOLINE;CYTIDINE DIPHOSPHATE CHOLINE;CDP-CHOLINE;cdp-cholin;cdp-colina;cereb;choline,hydroxide,5’-esterwithcytidine5’-(trihydrogenpyrophosphate),inne
分子式: C14H26N4O11P2
分子量: 488.32
EINECS號: 213-580-7
標準:醫藥級
含量:≥98.5%
性狀: 本品鈉鹽為白色或類白色粉末,無臭;易吸濕。本品在水中易溶,在乙醇、***、氯仿中不溶。有旋光性。
用途:該品是卵磷酯生物合成前體,能促使卵磷脂生物合成。該品可促進大腦功能的恢復和蘇醒。適用于腦外傷、中風后遺癥等的意識障礙,也用于中樞神經系統急性損傷所致意識障礙。
包裝:25kg/桶
舉報收藏 0評論 0
更多>本企業其它產品
來氟米特 CAS號: 75706-12-6 頭孢曲松鈉 CAS;74578-69-1 福多斯坦 CAS號: 13189-98-5 克洛索隆 CAS;60200-06-8 磷酸吡哆醛 CAS號: 54-47-7 4-甲基噻唑-5-甲醛 CAS號: 82294-70-0 三氯苯噠唑 CAS:68786-66-3 5-乙酰水楊酸甲酯 CAS;16475-90-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |